Isr Med Assoc J
The most recent articles from:
Isr Med Assoc J
-
Multicenter Study
Critical Stepwise Decline of Antibodies against SARS-CoV-2 among Chronic Hemodialysis Patients 180 Days Post Comirnaty Vaccine.
The reduced immune response of maintenance hemodialysis patients to coronavirus disease 2019 (COVID-19) vaccines is a major concern. ⋯ We recommend all patients on hemodialysis receive a booster COVID-19 vaccine 6 months after the second dose.